Kevin Lee Freeman, Chief Commercial Officer at Health Catalyst, Inc. (HCAT), sold 18,931 shares at $8.94 ($170K) on 2024-12-02, disclosed to the SEC on 2024-12-03.
Open-market sale of $170k HCAT by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.97 | 11,431 | $103K | 60.5% |
| 2 | $8.94 | 7,500 | $67K | 39.5% |
| Total | $8.96 avg | 18,931 | $170K | 100% |
| Filing → |